Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 489

1.

Resident memory and recirculating memory T cells cooperate to maintain disease in a mouse model of vitiligo.

Richmond JM, Strassner JP, Rashighi M, Agarwal P, Garg M, Essien KI, Pell LS, Harris JE.

J Invest Dermatol. 2018 Nov 10. pii: S0022-202X(18)32802-1. doi: 10.1016/j.jid.2018.10.032. [Epub ahead of print]

PMID:
30423329
2.

Physiotherapy in the neurotrauma intensive care unit: A scoping review.

Newman ANL, Gravesande J, Rotella S, Wu SS, Topp-Nguyen N, Kho ME, Harris JE, Fox-Robichaud A, Solomon P.

J Crit Care. 2018 Dec;48:390-406. doi: 10.1016/j.jcrc.2018.09.037. Epub 2018 Oct 3.

PMID:
30316038
3.

Mouse Model for Human Vitiligo.

Riding RL, Richmond JM, Harris JE.

Curr Protoc Immunol. 2018 Sep 25:e63. doi: 10.1002/cpim.63. [Epub ahead of print]

PMID:
30253067
4.

Reliability and validity of the shortened Singapore versions of the Chedoke Arm and Hand Activity Inventory.

Choo SX, Bosch J, Richardson J, Stratford P, Harris JE.

Int J Rehabil Res. 2018 Dec;41(4):297-303. doi: 10.1097/MRR.0000000000000318.

PMID:
30234732
5.

Comprehensive genetic screening: the prevalence of MODY gene variants in a population-based childhood diabetes cohort.

Johnson SR, Ellis JJ, Leo P, Anderson LK, Ganti U, Harris JE, Curran JA, McInerney-Leo A, Paramalingam N, Song X, Conwell LS, Harris M, Jones TW, Brown MA, Davis EA, Duncan EL.

Pediatr Diabetes. 2018 Sep 7. doi: 10.1111/pedi.12766. [Epub ahead of print]

PMID:
30191644
6.

Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU.

Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, Watson PL, Weinhouse GL, Nunnally ME, Rochwerg B, Balas MC, van den Boogaard M, Bosma KJ, Brummel NE, Chanques G, Denehy L, Drouot X, Fraser GL, Harris JE, Joffe AM, Kho ME, Kress JP, Lanphere JA, McKinley S, Neufeld KJ, Pisani MA, Payen JF, Pun BT, Puntillo KA, Riker RR, Robinson BRH, Shehabi Y, Szumita PM, Winkelman C, Centofanti JE, Price C, Nikayin S, Misak CJ, Flood PD, Kiedrowski K, Alhazzani W.

Crit Care Med. 2018 Sep;46(9):e825-e873. doi: 10.1097/CCM.0000000000003299.

PMID:
30113379
7.

Executive Summary: Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU.

Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, Watson PL, Weinhouse GL, Nunnally ME, Rochwerg B, Balas MC, van den Boogaard M, Bosma KJ, Brummel NE, Chanques G, Denehy L, Drouot X, Fraser GL, Harris JE, Joffe AM, Kho ME, Kress JP, Lanphere JA, McKinley S, Neufeld KJ, Pisani MA, Payen JF, Pun BT, Puntillo KA, Riker RR, Robinson BRH, Shehabi Y, Szumita PM, Winkelman C, Centofanti JE, Price C, Nikayin S, Misak CJ, Flood PD, Kiedrowski K, Alhazzani W.

Crit Care Med. 2018 Sep;46(9):1532-1548. doi: 10.1097/CCM.0000000000003259. No abstract available.

PMID:
30113371
8.

International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation.

Eleftheriadou V, Hamzavi I, Pandya AG, Grimes P, Harris JE, Huggins RH, Lim HW, Elbuluk N, Bhatia B, Tovar-Garza A, Nahhas AF, Braunberger T, Ezzedine K.

Br J Dermatol. 2018 Jul 21. doi: 10.1111/bjd.17013. [Epub ahead of print]

PMID:
30030843
9.

Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo.

Richmond JM, Strassner JP, Zapata L Jr, Garg M, Riding RL, Refat MA, Fan X, Azzolino V, Tovar-Garza A, Tsurushita N, Pandya AG, Tso JY, Harris JE.

Sci Transl Med. 2018 Jul 18;10(450). pii: eaam7710. doi: 10.1126/scitranslmed.aam7710.

PMID:
30021889
10.

Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation.

Mande P, Zirak B, Ko WC, Taravati K, Bride KL, Brodeur TY, Deng A, Dresser K, Jiang Z, Ettinger R, Fitzgerald KA, Rosenblum MD, Harris JE, Marshak-Rothstein A.

J Clin Invest. 2018 Jul 2;128(7):2966-2978. doi: 10.1172/JCI98219. Epub 2018 Jun 11.

11.

Cross-cultural adaptation and psychometric evaluation of the Singapore version of the Chedoke Arm and Hand Activity.

Choo SX, Bosch J, Richardson J, Stratford P, Harris JE.

Disabil Rehabil. 2018 May 22:1-8. doi: 10.1080/09638288.2018.1472817. [Epub ahead of print]

PMID:
29786453
12.

Interrater Reliability of Three Versions of the Chedoke Arm and Hand Activity Inventory.

Johnson D, Harris JE, Stratford P, Richardson J.

Physiother Can. 2018;70(2):133-140. doi: 10.3138/ptc.2016-70.

PMID:
29755169
13.

Motivation in rehabilitation and acquired brain injury: can theory help us understand it?

Kusec A, Velikonja D, DeMatteo C, Harris JE.

Disabil Rehabil. 2018 Apr 25:1-7. doi: 10.1080/09638288.2018.1467504. [Epub ahead of print]

PMID:
29693464
14.

Psychometric properties of measures of motivation and engagement after acquired brain injury.

Kusec A, DeMatteo C, Velikonja D, Harris JE.

Rehabil Psychol. 2018 Feb;63(1):92-103. doi: 10.1037/rep0000186.

PMID:
29553784
15.

Alopecia areata is a medical disease.

Korta DZ, Christiano AM, Bergfeld W, Duvic M, Ellison A, Fu J, Harris JE, Hordinsky MK, King B, Kranz D, Mackay-Wiggan J, McMichael A, Norris DA, Price V, Shapiro J, Atanaskova Mesinkovska N.

J Am Acad Dermatol. 2018 Apr;78(4):832-834. doi: 10.1016/j.jaad.2017.09.011. No abstract available.

PMID:
29548423
16.

Maternal Exercise Improves the Metabolic Health of Adult Offspring.

Harris JE, Baer LA, Stanford KI.

Trends Endocrinol Metab. 2018 Mar;29(3):164-177. doi: 10.1016/j.tem.2018.01.003. Epub 2018 Feb 3. Review.

PMID:
29402734
17.

Point mutation in p14ARF -specific exon 1β of CDKN2A causing familial melanoma and astrocytoma.

McInerney-Leo AM, Wheeler L, Sturm RA, Tan JM, Harris JE, Anderson L, Jagirdar K, Brown MA, Leo PJ, Soyer HP, Duncan EL.

Br J Dermatol. 2018 Apr;178(4):e263-e264. doi: 10.1111/bjd.16275. Epub 2018 Feb 19. No abstract available.

PMID:
29278422
18.

Building and Crossing the Translational Bridge: 2016 Alopecia Areata Research Summit Highlights.

Kranz D, Ellison A, Mesinkovska NA, Christiano AM, Hordinsky MK, Harris JE.

J Investig Dermatol Symp Proc. 2018 Jan;19(1):S3-S8. doi: 10.1016/j.jisp.2017.10.004.

PMID:
29273102
19.

Vitiligo-like depigmentation in patients receiving programmed cell death-1 inhibitor reflects active vitiligo.

Fukuda K, Harris JE.

J Am Acad Dermatol. 2018 Jan;78(1):e15-e16. doi: 10.1016/j.jaad.2017.07.058. No abstract available.

PMID:
29241799
20.

Lower incidence of myocardial infarction after smoke-free legislation enforcement in Chile.

Nazzal C, Harris JE.

Bull World Health Organ. 2017 Oct 1;95(10):674-682. doi: 10.2471/BLT.16.189894. Epub 2017 Aug 28. Erratum in: Bull World Health Organ. 2017 Nov 1;95(11):792.

21.

Biomechanical study of rod stress after pedicle subtraction osteotomy versus anterior column reconstruction: A finite element study.

Januszewski J, Beckman JM, Harris JE, Turner AW, Yen CP, Uribe JS.

Surg Neurol Int. 2017 Sep 6;8:207. doi: 10.4103/sni.sni_44_17. eCollection 2017.

22.

Impact of intraoperative factor concentrates on blood product transfusions during orthotopic liver transplantation.

Colavecchia AC, Cohen DA, Harris JE, Thomas JM, Lindberg S, Leveque C, Salazar E.

Transfusion. 2017 Dec;57(12):3026-3034. doi: 10.1111/trf.14328. Epub 2017 Sep 28.

PMID:
28960322
23.

Comparison of the sensitivity to change of the Functional Independence Measure with the Assessment of Motor and Process Skills within different rehabilitation populations.

Choo SX, Stratford P, Richardson J, Bosch J, Pettit SM, Ansley BJ, Harris JE.

Disabil Rehabil. 2017 Sep 10:1-8. doi: 10.1080/09638288.2017.1375033. [Epub ahead of print]

PMID:
28891345
24.

Impact of plain packaging of cigarettes on the risk perception of Uruguayan smokers: an experimental study.

Harris JE, Ares G, Gerstenblüth M, Machin L, Triunfo P.

Tob Control. 2018 Sep;27(5):513-518. doi: 10.1136/tobaccocontrol-2017-053639. Epub 2017 Sep 8.

PMID:
28887428
25.

Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.

Liu LY, Strassner JP, Refat MA, Harris JE, King BA.

J Am Acad Dermatol. 2017 Oct;77(4):675-682.e1. doi: 10.1016/j.jaad.2017.05.043. Epub 2017 Aug 18.

26.

Vitiligo: Mechanistic insights lead to novel treatments.

Frisoli ML, Harris JE.

J Allergy Clin Immunol. 2017 Sep;140(3):654-662. doi: 10.1016/j.jaci.2017.07.011. Epub 2017 Aug 1. Review.

PMID:
28778794
27.

Current and emerging treatments for vitiligo.

Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE; Vitiligo Working Group.

J Am Acad Dermatol. 2017 Jul;77(1):17-29. doi: 10.1016/j.jaad.2016.11.010. Review.

PMID:
28619557
28.

New discoveries in the pathogenesis and classification of vitiligo.

Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE; Vitiligo Working Group.

J Am Acad Dermatol. 2017 Jul;77(1):1-13. doi: 10.1016/j.jaad.2016.10.048. Review.

PMID:
28619550
29.

Healthcare Antibiotic Resistance Prevalence - DC (HARP-DC): A Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia.

Reuben J, Donegan N, Wortmann G, DeBiasi R, Song X, Kumar P, McFadden M, Clagon S, Mirdamadi J, White D, Harris JE, Browne A, Hooker J, Yochelson M, Walker M, Little G, Jernigan G, Hansen K, Dockery B, Sinatro B, Blaylock M, Harmon K, Iyengar P, Wagner T, Nelson JA; HARP Study Team.

Infect Control Hosp Epidemiol. 2017 Aug;38(8):921-929. doi: 10.1017/ice.2017.110. Epub 2017 Jun 15.

PMID:
28615088
30.

An in vitro evaluation of sagittal alignment in the cervical spine after insertion of supraphysiologic lordotic implants.

Blaskiewicz DJ, Harris JE, Han PP, Turner AW, Mundis GM.

Eur Spine J. 2018 Feb;27(2):433-441. doi: 10.1007/s00586-017-5110-y. Epub 2017 May 13.

PMID:
28501956
31.

Crossover Designs in Nutrition and Dietetics Research.

Harris JE, Raynor HA.

J Acad Nutr Diet. 2017 Jul;117(7):1023-1030. doi: 10.1016/j.jand.2017.03.017. Epub 2017 May 4.

PMID:
28479137
32.

Optimizing Vitiligo Management: Past, Present, and Future.

Harris JE.

Dermatol Clin. 2017 Apr;35(2):xi. doi: 10.1016/j.det.2017.01.001. No abstract available.

PMID:
28317535
33.

Vitiligo Pathogenesis and Emerging Treatments.

Rashighi M, Harris JE.

Dermatol Clin. 2017 Apr;35(2):257-265. doi: 10.1016/j.det.2016.11.014. Review.

34.

Chemical-Induced Vitiligo.

Harris JE.

Dermatol Clin. 2017 Apr;35(2):151-161. doi: 10.1016/j.det.2016.11.006. Review.

35.

Mixed-Methods Research in Nutrition and Dietetics.

Zoellner J, Harris JE.

J Acad Nutr Diet. 2017 May;117(5):683-697. doi: 10.1016/j.jand.2017.01.018. Epub 2017 Mar 8.

PMID:
28284525
36.

Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity.

Strassner JP, Rashighi M, Ahmed Refat M, Richmond JM, Harris JE.

J Am Acad Dermatol. 2017 May;76(5):847-855.e5. doi: 10.1016/j.jaad.2016.12.021. Epub 2017 Mar 1.

37.

The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo.

Mohammad TF, Al-Jamal M, Hamzavi IH, Harris JE, Leone G, Cabrera R, Lim HW, Pandya AG, Esmat SM.

J Am Acad Dermatol. 2017 May;76(5):879-888. doi: 10.1016/j.jaad.2016.12.041. Epub 2017 Feb 16.

PMID:
28216034
38.

CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice.

Richmond JM, Masterjohn E, Chu R, Tedstone J, Youd ME, Harris JE.

J Invest Dermatol. 2017 Apr;137(4):982-985. doi: 10.1016/j.jid.2016.10.048. Epub 2017 Jan 23. No abstract available.

39.

Promoting Therapists' Use of Motor Learning Strategies within Virtual Reality-Based Stroke Rehabilitation.

Levac DE, Glegg SM, Sveistrup H, Colquhoun H, Miller P, Finestone H, DePaul V, Harris JE, Velikonja D.

PLoS One. 2016 Dec 19;11(12):e0168311. doi: 10.1371/journal.pone.0168311. eCollection 2016.

40.

A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo.

Vanderweil SG, Amano S, Ko WC, Richmond JM, Kelley M, Senna MM, Pearson A, Chowdary S, Hartigan C, Barton B, Harris JE.

J Am Acad Dermatol. 2017 Jan;76(1):150-151.e3. doi: 10.1016/j.jaad.2016.06.015. No abstract available.

41.

CXCR4 identifies transitional bone marrow premonocytes that replenish the mature monocyte pool for peripheral responses.

Chong SZ, Evrard M, Devi S, Chen J, Lim JY, See P, Zhang Y, Adrover JM, Lee B, Tan L, Li JL, Liong KH, Phua C, Balachander A, Boey A, Liebl D, Tan SM, Chan JK, Balabanian K, Harris JE, Bianchini M, Weber C, Duchene J, Lum J, Poidinger M, Chen Q, Rénia L, Wang CI, Larbi A, Randolph GJ, Weninger W, Looney MR, Krummel MF, Biswas SK, Ginhoux F, Hidalgo A, Bachelerie F, Ng LG.

J Exp Med. 2016 Oct 17;213(11):2293-2314. Epub 2016 Oct 10.

42.

Understanding mechanisms of autoimmunity through translational research in vitiligo.

Strassner JP, Harris JE.

Curr Opin Immunol. 2016 Dec;43:81-88. doi: 10.1016/j.coi.2016.09.008. Epub 2016 Oct 17. Review.

43.

A knowledge translation intervention to enhance clinical application of a virtual reality system in stroke rehabilitation.

Levac D, Glegg SM, Sveistrup H, Colquhoun H, Miller PA, Finestone H, DePaul V, Harris JE, Velikonja D.

BMC Health Serv Res. 2016 Oct 6;16(1):557.

44.

Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease.

Richmond JM, Bangari DS, Essien KI, Currimbhoy SD, Groom JR, Pandya AG, Youd ME, Luster AD, Harris JE.

J Invest Dermatol. 2017 Feb;137(2):350-358. doi: 10.1016/j.jid.2016.09.016. Epub 2016 Sep 26.

45.

The effect of posterior polyester tethers on the biomechanics of proximal junctional kyphosis: a finite element analysis.

Bess S, Harris JE, Turner AW, LaFage V, Smith JS, Shaffrey CI, Schwab FJ, Haid RW Jr.

J Neurosurg Spine. 2017 Jan;26(1):125-133. doi: 10.3171/2016.6.SPINE151477. Epub 2016 Sep 9.

PMID:
27611508
46.

Sampling Serum in Patients With Vitiligo to Measure Disease Activity in the Skin.

Rashighi M, Harris JE.

JAMA Dermatol. 2016 Nov 1;152(11):1187-1188. doi: 10.1001/jamadermatol.2016.2501. No abstract available.

PMID:
27557448
47.

Serum chemokines herald disease activity and treatment response in vitiligo patients.

Rashighi M, Harris JE.

Br J Dermatol. 2016 Jun;174(6):1190-1. doi: 10.1111/bjd.14671. No abstract available.

PMID:
27317283
48.

Understanding autoimmunity of vitiligo and alopecia areata.

Rork JF, Rashighi M, Harris JE.

Curr Opin Pediatr. 2016 Aug;28(4):463-9. doi: 10.1097/MOP.0000000000000375. Review.

49.

Mutations in human C2CD3 cause skeletal dysplasia and provide new insights into phenotypic and cellular consequences of altered C2CD3 function.

Cortés CR, McInerney-Leo AM, Vogel I, Rondón Galeano MC, Leo PJ, Harris JE, Anderson LK, Keith PA, Brown MA, Ramsing M, Duncan EL, Zankl A, Wicking C.

Sci Rep. 2016 Apr 20;6:24083. doi: 10.1038/srep24083.

50.

Mutations in LTBP3 cause acromicric dysplasia and geleophysic dysplasia.

McInerney-Leo AM, Le Goff C, Leo PJ, Kenna TJ, Keith P, Harris JE, Steer R, Bole-Feysot C, Nitschke P, Kielty C, Brown MA, Zankl A, Duncan EL, Cormier-Daire V.

J Med Genet. 2016 Jul;53(7):457-64. doi: 10.1136/jmedgenet-2015-103647. Epub 2016 Apr 11.

PMID:
27068007

Supplemental Content

Loading ...
Support Center